Rsdl
Ended Awarded Last action
- Contract number
- SPE2D626F630Q
- Awardee
-
Canadian Commercial Corporation UEI FA38CTVQM319
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,181
Award facts
- Contract value 100% obligated
- $4,180.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain division awarded a delivery order valued at $4,180.98 to Canadian Commercial Corporation (CCC) on December 2, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL), a critical medical countermeasure used in chemical, biological, radiological, and nuclear (CBRN) defense operations. This delivery order, with an ultimate completion date of February 18, 2026, represents a child contract issued against a larger Indefinite Delivery Contract framework. The contract carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation owned by the Government of Canada. Performance will be completed at CCC's headquarters in Ottawa, Ontario, utilizing firm fixed-price pricing.
Canadian Commercial Corporation serves as a prime contractor facilitating government-to-government procurement relationships between U.S. defense agencies and Canadian manufacturers and exporters. CCC has an established track record of delivering medical supplies and specialized equipment to the Defense Logistics Agency across multiple divisions, including aviation, land and maritime operations, and subsistence. The corporation maintains three active Indefinite Delivery Contracts with various U.S. military commands and operates under substantially larger IDV frameworks with the Defense Logistics Agency and Army Materiel Command, demonstrating sustained strategic importance to U.S. defense logistics operations with documented contract activity extending through 2030 and 2031.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Emergent Biosolutions Canada Inc. | $0 |
Quick answers
Who was awarded contract SPE2D626F630Q?
SPE2D626F630Q was awarded to Canadian Commercial Corporation by Medical Supply Chain (Troop Support) on December 2, 2025.
How much is contract SPE2D626F630Q worth?
The government has obligated $4,181 on SPE2D626F630Q.
Is contract SPE2D626F630Q an order under another contract?
Yes. SPE2D626F630Q is a delivery order under SPE2DP23D0001, an indefinite delivery contract.
Was contract SPE2D626F630Q competed?
The extent of competition for SPE2D626F630Q was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award